EGFR and non-small cell lung carcinoma: In non-small-cell lung cancer (NSCLC) patients, the frequency of EGFR-TK domain mutations was found to be higher among Asian patients versus patients of other ethnicities (30% versus 8%, p < 0.001) [1].